184
Results-
NewsPierre Fabre Laboratories on the global stage at two international congresses in September: ESMO and EADVCreated on : - Last modified on :Pierre Fabre Laboratories’ mission is to innovate constantly, particularly in the fields of oncology and dermatology. This mission is accomplished alongside healthcare professionals, the company’s day-to-day partners. Driven by a constant desire to share expertise and present the company’s latest therapeutic innovations, Pierre Fabre teams are taking part in two major events in September: ESMO and EADV.
-
NewsWorld Lymphoma Awareness Day – Understanding Post-Transplant Lymphoproliferative Disorders (PTLD)Created on : - Last modified on :Join us in recognizing World Lymphoma Awareness Day, 15th September, a day dedicated to raising awareness of lymphomas, which are cancers of the lymphocytes or white blood cells. This day sheds light on a type of cancer with more than 80 subtypes and that affects up to 864,000 people world wide1,2. One of these subtypes is Post-Transplant Lymphoproliferative disorder (PTLD).
-
NewsA Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany.Created on : - Last modified on :
-
NewsA Medical Science Liaison (MSL) Transforming the Therapeutic Landscape in China.Created on : - Last modified on :The script of the video.
-
NewsA Medical Science Liaison (MSL) Dedicated to Changing Patient Lives in the United Kingdom.Created on : - Last modified on :The script of the video.
-
NewsLaunch of the Gustave Roussy PrizeCreated on : - Last modified on :An initiative supported by Pierre Fabre Laboratories in favor of scientific innovation in oncology. Villejuif, November 18, 2024 – On the occasion of the 150th anniversary of the birth of Professor Gustave Roussy and approaching the 100th anniversary of the Institute that bears his name, an international prize is being launched to reward scientific innovation in oncology. The Gustave Roussy Prize, endowed with €200,000 per year, aims to honor researchers whose discoveries have a significant impact on the care of cancer patients.
-
NewsMattia Pagnani: A Medical Science Liaison (MSL) Aiming to Enhance Patient Outcomes in ItalyCreated on : - Last modified on :
-
NewsJerry Liu: A Medical Science Liaison (MSL) Shaping the Future of Healthcare in TaiwanCreated on : - Last modified on :The script of the video.
-
NewsPierre Fabre at the JP Morgan Healthcare Conference: strategic partnerships to accelerate innovation and develop the company's R&D and product portfolio.Created on : - Last modified on :From January 12 to 16, Eric Ducournau and his team were present at the key event for pharmaceuticals, biotechs and healthcare investors. They took part in over 100 meetings with innovative companies, strategic partners and investors. By participating in this latest edition of the JP Morgan Healthcare Conference, Pierre Fabre has reaffirmed its commitment to becoming a global player in the field of innovative medicines.
-
NewsAs major partner of the new Gustave Roussy Prize, Pierre Fabre celebrates innovation in oncologyCreated on : - Last modified on :The new Gustave Roussy International Prize, of which Pierre Fabre Laboratories is the major partner, will be awarded each year to a researcher whose work has demonstrated a major impact on the care of cancer patients.
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.